MIC
GILD icon

Mubadala Investment Company’s Gilead Sciences GILD Stock Holding History

Mubadala Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Sell
36,993
-63,185
-63% -$8.85M 0.03% 29
2025
Q4 		$12.3M Buy
100,178
+23,337
+30% +$2.84M 0.07% 15
2025
Q3 		$8.53M Buy
76,841
+4,557
+6% +$518K 0.05% 15
2025
Q2 		$8.01M Buy
72,284
+29,536
+69% +$3.14M 0.04% 12
2025
Q1 		$4.79M Sell
42,748
-1,160
-3% -$120K 0.03% 9
2024
Q4 		$4.06M Buy
+43,908
New +$3.95M 0.02% 17

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mubadala Investment Company's GILD Position: Q1 2026 in Review

Mubadala Investment Company reduced its Gilead Sciences (GILD) stake by 63% in Q1 2026, selling an estimated $8.85M and leaving 36,993 shares worth $5.16M. The position accounts for 0.03% of the portfolio, ranked #29.

Mubadala Investment Company first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.3M in Q4 2025. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mubadala Investment Company held 36,993 shares of Gilead Sciences worth $5.16M as of Q1 2026.
  • Mubadala Investment Company sold 63,185 Gilead Sciences shares in Q1 2026, an estimated $8.85M.
  • Gilead Sciences made up 0.03% of Mubadala Investment Company's portfolio in Q1 2026, its #29 holding.
  • Mubadala Investment Company first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Mubadala Investment Company's Gilead Sciences position peaked at $12.3M in Q4 2025.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mubadala Investment Company's 13F filing for Q1 2026, filed 15 May 2026.